ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
07 nov. 2022 19h12 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022
27 avr. 2022 08h15 HE
|
ProPhase Labs, Inc.
Garden City, NY, April 27, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present...
ProPhase Labs Announces Record COVID-19 Testing in Q4 2021
13 janv. 2022 08h15 HE
|
ProPhase Labs, Inc.
Q1 2022 Testing Volumes will Significantly Exceed Previous Record Results from Q1 2021 Significant year-over-year growth expected for the next four quarters Garden City, NY, Jan. 13, 2022 (GLOBE...